Budesonide Orodispersible Tablet for the Treatment of Refractory Esophageal Lichen Planus
Esophageal lichen planus is an uncommon but highly morbid condition where effective treatments are limited. Diagnosis may be challenging and requires a high degree of clinical suspicion considering endoscopic, histopathological, esophageal, and extraesophageal manifestations. We describe a severe case of esophageal lichen planus and recurrent esophageal stricture that was refractory to acid suppression, local and systemic steroid formulations, and dilatation. We present the first reported use of budesonide orodispersible tablet for this condition, including the excellent clinical, endoscopic, and histopathological response.
Authors
- Thomas Skinner (ORCID: https://orcid.org/0000-0001-9276-1955)
- Sharron Liang (ORCID: https://orcid.org/0000-0002-5324-2826)
- Santosh Sanagapalli (ORCID: https://orcid.org/0000-0003-3145-1050)
Institutions
- UNSW Sydney (AU)
- St Vincent's Hospital Melbourne (AU)
- St Vincent's Hospital Sydney (AU)
Publication Details
- Journal
- ACG Case Reports Journal
- Published
- 2024-08-01
- DOI
- https://doi.org/10.14309/crj.0000000000001460
- Citations
- 4
- Primary Topic
- Oral Health Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.60
Funders
- Dr. Falk Pharma